Show simple item record

dc.contributor.authorRyan, Jeremy
dc.contributor.authorLetai, Anthony
dc.contributor.authorDutta, Sanjib
dc.contributor.authorChen, T. Scott
dc.contributor.authorKougentakis, Christos
dc.contributor.authorKeating, Amy E.
dc.date.accessioned2017-06-16T22:34:39Z
dc.date.available2017-06-16T22:34:39Z
dc.date.issued2017-06-16
dc.identifier.issn0022-2836
dc.identifier.issn1089-8638
dc.identifier.urihttp://hdl.handle.net/1721.1/109994
dc.description.abstractThe Bcl-2 family of proteins plays a critical role regulating apoptosis, and pro-survival Bcl-2 family members are important therapeutic targets due to their overexpression in different cancers. Pro-apoptotic Bcl-2 homology 3 (BH3)-only proteins antagonize pro-survival Bcl-2 protein functions by binding directly to them, and a sub-class of BH3-only proteins termed sensitizers can initiate apoptosis via this mechanism in response to diverse signals. The five pro-survival proteins Bcl-x[subscript L], Mcl-1, Bcl-2, Bcl-w and Bfl-1 differ in their binding preferences, with Bcl-x[subscript L], Bcl-2 and Bcl-w sharing similar interaction profiles for many natural sensitizers and small molecules. Peptides that bind selectively to just one or a subset of family members have shown utility in assays that diagnose apoptotic blockades in cancer cells and as reagents for dissecting apoptotic mechanism. Combining computational design, combinatorial library screening and rational mutagenesis, we designed a series of BH3 sensitizer peptides that bind Bcl-x[subscript L] with sub-nanomolar affinity and selectivity up to 1000-fold over each of the four competing pro-survival proteins. We demonstrate the efficacy of our designed BH3 peptides in assays that differentiate between cancer cells that are dependent on different pro-survival proteins.en_US
dc.description.sponsorshipNational Institute of General Medical Sciences (U.S.) (award P50-GM068762)en_US
dc.description.sponsorshipNational Institute of General Medical Sciences (U.S.) (award GM110048)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.jmb.2014.09.030en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titlePotent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-xLen_US
dc.typeArticleen_US
dc.identifier.citationDutta, Sanjib, Jeremy Ryan, T. Scott Chen, Christos Kougentakis, Anthony Letai, and Amy E. Keating. “Potent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-xL.” Journal of Molecular Biology 427, no. 6 (March 2015): 1241–1253. © 2014 Elsevier Ltd.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorDutta, Sanjib
dc.contributor.mitauthorChen, T. Scott
dc.contributor.mitauthorKougentakis, Christos
dc.contributor.mitauthorKeating, Amy E.
dc.relation.journalJournal of Molecular Biologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsDutta, Sanjib; Ryan, Jeremy; Chen, T. Scott; Kougentakis, Christos; Letai, Anthony; Keating, Amy E.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-4074-8980
dspace.mitauthor.errortrue
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record